Stem-cell Therapies For Brain More Complicated Than Thought
ScienceDaily (Nov. 29, 2007) — An MIT research team's latest finding
suggests that stem cell therapies for the brain could be much more
complicated than previously thought.
MIT scientists report that adult stem cells produced in the brain are
pre-programmed to make only certain kinds of connections- - making it
impossible for a neural stem cell originating in the brain to be
transplanted to the spinal cord, for instance, to take over functions
for damaged cells.
Some researchers hope to use adult stem cells produced in the brain
to replace neurons lost to damage and diseases such as Alzheimer's.
The new study calls this into question.
"It is wishful thinking to hope that adult stem cells will be able to
modify themselves so that they can become other types of neurons lost
to injury or disease," said Carlos E. Lois, assistant professor of
neuroscience in MIT's Picower Institute for Leaning and Memory.
In developing embryos, stem cells give rise to all the different
types of cells that make up the body--skin, muscle, nerve, brain,
blood and more. Some of these stem cells persist in adults and give
rise to new skin cells, stomach lining cells, etc. The idea behind
stem-cell therapy is to use these cells to repair tissue or organs
ravaged by disease.
To realize this potential, the stem cells have to be "instructed" to
become liver cells, heart cells or neurons. The MIT study, which
looked only at adult neural stem cells, suggests it will be necessary
to learn how to program any kind of stem cell--embryonic, adult or
those derived through other means--to produce specific types of
functioning neurons. Without this special set of instructions, a
young neuron will only connect with the partners for which it was pre-
programmed.
The adult brain harbors its own population of stem cells that spawn
new neurons for life. The MIT study shows that a neural stem cell is
irreversibly committed to produce only one type of neuron with a pre-
set pattern of connections. This means that a given neuronal stem
cell can have only limited use in replacement therapy.
"A stem cell that produces neurons that could be useful to replace
neurons in the cerebral cortex (the type of neurons lost in
Alzheimer's disease) will be most likely useless to replace neurons
lost in the spinal cord," said Lois, who also holds an appointment in
MIT's Department of Brain and Cognitive Sciences. "Moreover, because
there are many different types of neurons in the cerebral cortex, it
is likely that we will have to figure out how to program stem cells
to become many different types of neurons, each of them with a
different set of pre-specified connections.
"In the stem cell field, it is generally thought that the main
limitation to achieve brain repair is simply for the new neurons to
reach a given brain region and to ensure their survival. Once there,
it has been assumed that stem cells will 'know what to do' and will
become the type of neuron that is missing. It seems that is not the
case at all. Our experiments indicate that things are much more
complicated,
Lois and colleagues from MIT's departments of Brain and Cognitive
Sciences and Biology found that the stem cells give rise to neurons
that become a very specific neuronal type that is already pre-
specified to make a very defined set of connections and not others.
Even if the stem cells are transplanted to other parts of the brain,
they do not change the type of connections they are programmed to
make.
"This suggests that we will have to know much more about the
different types of neuronal stem cells, and to identify the
characteristic features of their progeny," Lois said. "We may need to
have access to many different types of 'tailored' stem cells that
give rise to many different types of neurons with specific
connections. In addition, we may need a combination of several of
these tailored stem cells to eventually be able to replace the
different types of neurons lost in a given brain region.
The full study was published in the Public Library of Science (PloS)
Biology on Nov. 13.
Lois' colleagues are Picower Institute postdoctoral fellow Wolfgang
Kelsch, lead author of the work; biology undergraduate Colleen P.
Mosely, and Brain and Cognitive Sciences graduate student Chia-Wei
Lin.
This work is supported by the National Institutes of Health.
Adapted from materials provided by Massachusetts Institute of
Technology.
Need to cite this story in your essay, paper, or report? Use one of
the following formats:
MLA Massachusetts Institute of Technology (2007, November 29). Stem-
cell Therapies For Brain More Complicated Than Thought. ScienceDaily.
Retrieved December 6, 2007, from http://www.scienced
/releases/2007/
http://www.scienced
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
